Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant - Wikidata - awgldk - TriplyDB

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

http://www.wikidata.org/entity/Q35080697

about

Alum: an old dog with new tricks Role of T cell-nuclear factor κB in transplantation High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy The Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer Therapeutics Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival.Maternal undernutrition and the ovine acute phase response to vaccination.Evidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRR Regulation of CD8+ T cell responses to infection with parasitic protozoa.Genetic deletion of AEG-1 prevents hepatocarcinogenesis.RETRACTED: Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.Cell-intrinsic role for NF-kappa B-inducing kinase in peripheral maintenance but not thymic development of Foxp3+ regulatory T cells in mice.NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice Targeting signaling factors for degradation, an emerging mechanism for TRAF functions A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses An epigenetic vaccine model active in the prevention and treatment of melanoma NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation Expression of CD1d and ligand-induced cytokine production are tissue specific in mucosal epithelia of the human lower reproductive tract Integrating a 'danger' signal into molecular chaperoning to improve vaccination against cancer.Targeting intracellular signaling: a novel approach to vaccination.Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.NF-κB inducing kinase: a key regulator in the immune system and in cancer MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.Targeting lentiviral vectors for cancer immunotherapy.Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production.Novel immunotherapies for the treatment of melanoma.Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.IKKβ-induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vector.Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.Engineering Grp170-based immune modulators for cancer immunotherapy.Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.High content, high-throughput screening for small molecule inducers of NF-κB translocation.

P2860

Q26752643-8BA90D21-BBA1-4CF2-A066-B0EA2F518137 Q26852416-2C49DC68-93CC-4191-BEF3-9D29A0A19E1C Q26853566-5AA8AE26-2541-44E0-B868-0A8DAB340381 Q27026256-0119D749-754D-401D-93A2-44DBB2E8F0AA Q33297014-257E757B-7F55-454D-B327-F177CC0CAF94 Q33314969-9F035AF6-D52F-45E0-A5D6-1333194EF8C9 Q33884220-7AE7B1A6-8ECF-4591-B722-CFC81223ED98 Q34108177-E2DF590D-87EF-4801-83D4-018EE8D1CA1B Q34438436-DA49E18F-C77E-4D69-99C6-EDE8C6678615 Q34621544-5FCF1CB5-88CB-4E79-9E8D-B9A3A614E2E3 Q34998157-76C9FB8D-4BA4-4F7C-ACB9-C12F39AA7BA4 Q35000966-DC698B6A-EAFD-41A3-B28C-06748EE6C9AB Q35570169-00B26B91-E3D4-4E0A-A57E-76958FE93368 Q35759267-69D1B30E-D266-4BE4-B942-D7DC99AED85E Q35990046-E4442BB9-56F0-420D-9F6E-6393A9B9FA90 Q36440002-1A153403-459B-4DCB-A63F-2008D6EB06EE Q36493668-4A1C499F-9FE8-482B-AE0A-B503FC96AA8A Q36747156-57E10087-89F8-4DF0-BF44-D83AFD684D07 Q36929632-C7C69A7D-3CE9-432D-AFF7-8CFCCAFE064B Q37123459-F048D2A9-A1CB-4F62-831D-5B583CBCBF6D Q37164038-0A11557F-DCC6-431B-A36C-6BD3DD193BD7 Q37621566-DC5BAA17-1DD1-4D97-9245-ED2D16A65116 Q37635491-9C032C33-FFED-4844-998D-56C6C6760F5F Q37777775-22A09ABC-5506-4B43-BEFC-3FEB757B89BD Q38040302-6EE130E3-CAE9-44AB-A6B9-E7CA92EFCF64 Q38043924-9E3CCB38-5C9F-4A7B-A098-4B34970D971C Q38517521-12DA564E-83D1-4F4B-9BE5-1F29013075CD Q38824190-340D1778-85A5-4EE6-B8CF-9C4B945FE63E Q39235934-8B08CF46-138B-4F11-AECB-15AB0B2016F4 Q39649593-0219EDF2-2430-4BC1-83F0-3C2378A8F28F Q41879210-299BCABF-1D1C-4915-A45D-BE7CF94F5C9D Q41952315-70A3D341-34C0-4A5D-A4EA-B87CA8802531 Q43084713-FC6F05AA-BBE4-498C-9610-72C8239C8290 Q50788340-426CD6EF-BD56-4E2E-AB58-904DE5F8D8A2 Q55447884-00B4F109-CF33-470D-AA4B-7881812CA844

P2860

Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant

http://www.wikidata.org/entity/Q35080697

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@ast

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@en

type

label

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@ast

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@en

prefLabel

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@ast

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@en

P1433

Q35080697-DE000945-9B80-44F2-8E22-9DF2346C9D43

P1476

Q35080697-A962C94C-1D04-4109-AF72-4FA05E471D48

P2093

Q35080697-161FC9B8-BE88-4515-841D-9675B8B2D74F

Q35080697-3B89BB4F-D280-45B0-B0F9-F1AA2413C84A

Q35080697-967BF39F-8E3B-4884-A21A-61B916005483

Q35080697-A6C93CDB-0D18-4BE6-A722-8C1B2DF77108

P2860

Q35080697-0457508A-D17D-41C8-860B-39D739EA12D3

Q35080697-04CCC90E-976D-4DB8-B8EC-04B5575A8A3A

Q35080697-09D906D4-7132-4AA7-B019-A70E16B1AA05

Q35080697-0DC6394D-A9A4-4864-9066-EC6D7B410975

Q35080697-115A3624-658A-43CA-8ED0-28254F5A30F2

Q35080697-1C554431-F33F-45C0-9053-E85AED4EAE15

Q35080697-1E412B7F-1ABF-4A34-A34E-EBEB8EFFE063

Q35080697-2B37D7C5-E9AB-452B-A367-A27A8C0F21C9

Q35080697-303B84D1-D1EB-41D9-92DB-2A9FEDE7D751

Q35080697-356659FB-FC7A-46F4-837F-92D4AB8029C6

P304

Q35080697-0EA43E43-8B16-4A18-A52A-662DD573E8A1

P31

Q35080697-FE839074-A7E6-4881-88FF-EC4F84BE0AC3

P356

Q35080697-CC7F413D-6AD1-4185-97E0-37D4E00D4E65

P407

Q35080697-EE4FCA8E-6861-4C59-A6DB-E97CE00FADC3

P433

Q35080697-98F93F0A-E88E-42C1-9378-95B913C33C6E

P478

Q35080697-23B56EC8-0143-4447-9989-8D5510F218C4

P50

Q35080697-44865542-1E3D-44E8-9B3C-3CD55735C5F5

P577

Q35080697-5C8F528E-4CF1-4DC7-833B-E1B2F8708C04

P5875

Q35080697-3905B120-5746-4B69-B8BC-1ABEBB6A4EFD

P698

Q35080697-1C86A803-D810-4FDA-AC9C-0C36E635F244

P921

Q35080697-E6D7E40B-E49D-4392-AE6B-7A81C907364A

P932

Q35080697-452BC385-06E2-4D45-A97B-BB4ABEDDDBD7

P356

PNAS.0603493103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Activation of NF-kappaB by the ...... as a powerful vaccine adjuvant

@en

P2093

Andreakos E

http://www.w3.org/2001/XMLSchema#string

Feldmann M

http://www.w3.org/2001/XMLSchema#string

Foxwell BM

http://www.w3.org/2001/XMLSchema#string

Williams RO

http://www.w3.org/2001/XMLSchema#string

P2860

NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1

Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors.

Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells.

Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

P304

14459-14464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0603493103

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6820489

http://www.w3.org/2001/XMLSchema#string

P698

16971487

http://www.w3.org/2001/XMLSchema#string

P921

P932

1599984

http://www.w3.org/2001/XMLSchema#string